Survival until first progression (FPS) rates of patients with NSCLC or LUAD were correlated with FOXM1/PLK1 expression, similar to the correlation with OS (NSCLC, n = 982, HR = 1.75, log-rank P = 1.2e-08; LUAD, n = 461, HR = 2.58, log-rank P = 5.3e-09; Fig. S2e-f). This evidence concerns the gene PLK1 and non-small cell lung carcinoma.